208 related articles for article (PubMed ID: 28579578)
21. Short communication: Expression of T-box 2 and 3 in the bovine mammary gland.
Hoffman ML; McFadden KK; Hoagland TA; Kazmer GW; Govoni KE
J Dairy Sci; 2014 Jul; 97(7):4322-8. PubMed ID: 24767885
[TBL] [Abstract][Full Text] [Related]
22. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
[TBL] [Abstract][Full Text] [Related]
23. Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of Connexin43.
Boogerd KJ; Wong LY; Christoffels VM; Klarenbeek M; Ruijter JM; Moorman AF; Barnett P
Cardiovasc Res; 2008 Jun; 78(3):485-93. PubMed ID: 18285513
[TBL] [Abstract][Full Text] [Related]
24. Essential roles of Tbx3 in embryonic skin development during epidermal stratification.
Ichijo R; Iizuka Y; Kubo H; Toyoshima F
Genes Cells; 2017 Mar; 22(3):284-292. PubMed ID: 28205312
[TBL] [Abstract][Full Text] [Related]
25. COL1A2 is a TBX3 target that mediates its impact on fibrosarcoma and chondrosarcoma cell migration.
Omar R; Cooper A; Maranyane HM; Zerbini L; Prince S
Cancer Lett; 2019 Sep; 459():227-239. PubMed ID: 31202624
[TBL] [Abstract][Full Text] [Related]
26. Transcription factor Tbx3 is required for the specification of the atrioventricular conduction system.
Bakker ML; Boukens BJ; Mommersteeg MT; Brons JF; Wakker V; Moorman AF; Christoffels VM
Circ Res; 2008 Jun; 102(11):1340-9. PubMed ID: 18467625
[TBL] [Abstract][Full Text] [Related]
27. Mouse TBX3 mutants suggest novel molecular mechanisms for Ulnar-mammary syndrome.
Frank DU; Emechebe U; Thomas KR; Moon AM
PLoS One; 2013; 8(7):e67841. PubMed ID: 23844108
[TBL] [Abstract][Full Text] [Related]
28. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
[TBL] [Abstract][Full Text] [Related]
29. Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway.
Jerome-Majewska LA; Jenkins GP; Ernstoff E; Zindy F; Sherr CJ; Papaioannou VE
Dev Dyn; 2005 Dec; 234(4):922-33. PubMed ID: 16222716
[TBL] [Abstract][Full Text] [Related]
30. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
31. Development of a subset of forelimb muscles and their attachment sites requires the ulnar-mammary syndrome gene Tbx3.
Colasanto MP; Eyal S; Mohassel P; Bamshad M; Bonnemann CG; Zelzer E; Moon AM; Kardon G
Dis Model Mech; 2016 Nov; 9(11):1257-1269. PubMed ID: 27491074
[TBL] [Abstract][Full Text] [Related]
32. Establishment of the TBX-code reveals aberrantly activated T-box gene TBX3 in Hodgkin lymphoma.
Nagel S; Meyer C
PLoS One; 2021; 16(11):e0259674. PubMed ID: 34807923
[TBL] [Abstract][Full Text] [Related]
33. Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation.
Carlson H; Ota S; Song Y; Chen Y; Hurlin PJ
Oncogene; 2002 May; 21(24):3827-35. PubMed ID: 12032820
[TBL] [Abstract][Full Text] [Related]
34. TBX3 regulates splicing in vivo: a novel molecular mechanism for Ulnar-mammary syndrome.
Kumar P P; Franklin S; Emechebe U; Hu H; Moore B; Lehman C; Yandell M; Moon AM
PLoS Genet; 2014 Mar; 10(3):e1004247. PubMed ID: 24675841
[TBL] [Abstract][Full Text] [Related]
35. The T-box transcription factor Tbx2: its role in development and possible implication in cancer.
Abrahams A; Parker MI; Prince S
IUBMB Life; 2010 Feb; 62(2):92-102. PubMed ID: 19960541
[TBL] [Abstract][Full Text] [Related]
36. Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression.
Suzuki A; Sekiya S; Büscher D; Izpisúa Belmonte JC; Taniguchi H
Development; 2008 May; 135(9):1589-95. PubMed ID: 18356246
[TBL] [Abstract][Full Text] [Related]
37. Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome.
Davenport TG; Jerome-Majewska LA; Papaioannou VE
Development; 2003 May; 130(10):2263-73. PubMed ID: 12668638
[TBL] [Abstract][Full Text] [Related]
38. The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor.
Peres J; Kwesi-Maliepaard EM; Rambow F; Larue L; Prince S
Cancer Lett; 2017 Oct; 405():111-119. PubMed ID: 28757416
[TBL] [Abstract][Full Text] [Related]
39. A Fresh Look on T-Box Factor Action in Early Embryogenesis (T-Box Factors in Early Development).
Bertolessi M; Linta L; Seufferlein T; Kleger A; Liebau S
Stem Cells Dev; 2015 Aug; 24(16):1833-51. PubMed ID: 25952667
[TBL] [Abstract][Full Text] [Related]
40. Genetic and functional analysis of the TBX3 gene promoter in indirect inguinal hernia.
Zhao Z; Tian W; Wang L; Wang H; Qin X; Xing Q; Pang S; Yan B
Gene; 2015 Jan; 554(1):101-4. PubMed ID: 25455105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
